Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • Apoptosis
    (3)
  • Mitochondrial Metabolism
    (3)
  • Acyltransferase
    (2)
  • Endogenous Metabolite
    (2)
  • CPT
    (1)
  • MDM-2/p53
    (1)
  • Others
    (4)
TargetMol | Tags By ResearchField
  • Metabolism
    (6)
  • Cancer
    (2)
Filter
Search Result
Results for "

carnitine palmitoyltransferase-1

" in TargetMol Product Catalog.
  • Inhibitors & Agonists
    8
    TargetMol | All_Pathways
  • Reagent Kits
    1
    TargetMol | Reagent_Kits
  • Recombinant Protein
    2
    TargetMol | Recombinant_Protein
  • Antibody Products
    3
    TargetMol | Antibody_Products
  • Oligonucleotides
    2
    TargetMol | All_Pathways
  • Oxfenicine
    4-Hydroxy-L-phenylglycine
    T478532462-30-9
    Oxfenicine (4-Hydroxy-L-phenylglycine) is a carnitine palmitoyltransferase-1 inhibitor. Oxfenicine improves whole-body glucose tolerance and insulin sensitivity in high-fat diet-induced obese mouse with insulin resistance.
    • $40
    In Stock
    Size
    QTY
  • McN3716
    NSC359682, Methyl palmoxirate
    T1197869207-52-9In house
    McN3716 is a carnitine palmitoyltransferase I (CPT-1) inhibitor used for researching metabolic diseases.
    • $210
    In Stock
    Size
    QTY
  • Teglicar HCl
    Teglicar, ST-1326, ST1326, ST 1326, 4-trimethylammonio-TDCAB
    T202545908566-80-3
    Teglicar (also known as ST1326) is a selective reversible inhibitor of carnitine palmitoyltransferase 1 (L-CPT1), the liver isoform. It reduces ketogenesis and glucose production, decreases gluconeogenesis, and enhances glucose homeostasis.
    • $1,520
    8-10 weeks
    Size
    QTY
  • Etomoxir sodium salt
    (R)-Etomoxir sodium salt
    T4535828934-41-4
    Etomoxir sodium salt ((R)-Etomoxir sodium salt) is a carnitine palmitoyltransferase 1a (CPT-1a) inhibitor that inhibits fatty acid oxidation (FAO). Etomoxir sodium salt has antitumor activity.
    • $30
    In Stock
    Size
    QTY
    TargetMol | Citations Cited
  • Malonyl CoA
    T73829524-14-1
    Malonyl CoA serves as a substrate in fatty acid biosynthesis while inhibiting fatty acid oxidation. It also acts as a reversible inhibitor of mitochondrial carnitine palmitoyltransferase (CPT) 1 [1] [2].
    • Inquiry Price
    Inquiry
    Size
    QTY
  • CPT2
    Carnitine palmitoyltransferase 2
    T785691670277-66-3
    Carnitine palmitoyltransferase 2 (CPT2), an enzyme involved in fatty acid oxidation, serves as a prognostic biomarker for colorectal cancer (CRC). Overexpression of CPT2 activates phosphorylated p53, enhancing its expression, which in turn suppresses tumor growth and induces apoptosis. Conversely, a deficiency in CPT2 leads to the prevalent hereditary disorder of long-chain fatty acid oxidation in skeletal muscle. Additionally, the downregulation of CPT2 correlates strongly with the advancement of multiple cancers, highlighting its importance in cancer research [1] [2].
    • Inquiry Price
    Inquiry
    Size
    QTY
  • 4-Hydroxyphenylglyoxylic Acid
    UK 22486
    T8376715573-67-8
    4-Hydroxyphenylglyoxylic acid, an active metabolite of the prodrug oxfenicine, functions as an inhibitor of carnitine palmitoyltransferase 1 (CPT1). It effectively inhibits CPT1 in isolated rat liver mitochondria at concentrations of 200 to 1,000 µM and restricts oleate oxidation in isolated rat hepatocytes.
    • $142
    35 days
    Size
    QTY
  • Malonyl CoA tetralithium
    Malonyl coenzyme A tetralithium
    TN7723116928-84-8
    Malonyl CoA tetralithium (Malonyl coenzyme A), serves as a substrate in fatty acid biosynthesis and functions as an inhibitor of fatty acid oxidation. Additionally, it acts as a reversible inhibitor of mitochondrial carnitine palmitoyltransferase (CPT) 1 [1] [2].
    • Inquiry Price
    Inquiry
    Size
    QTY